HCM
CMD

HMS Capital Management’s Cantel Medical Corporation CMD Stock Holding History

HMS Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-900
Closed -$89K – 219
2018
Q2 		$89K Hold
900
– – 0.05% 177
2018
Q1 		$100K Buy
900
+500
+125% +$56K 0.07% 152
2017
Q4 		$41K Hold
400
– – 0.03% 139
2017
Q3 		$38K Hold
400
– – 0.03% 143
2017
Q2 		$31K Hold
400
– – 0.03% 144
2017
Q1 		$29K Hold
400
– – 0.03% 129
2016
Q4 		$32K Buy
+400
New +$31.1K 0.03% 113

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HMS Capital Management's CMD Position: Q3 2018 in Review

HMS Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 4,793 shares — an estimated $471K sold.

HMS Capital Management first reported a position in CMD in Q3 2016 and held it in 8 quarters. The position peaked at $841K in Q3 2016. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • HMS Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • HMS Capital Management sold 4,793 Cantel Medical Corporation shares in Q3 2018, an estimated $471K.
  • HMS Capital Management first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 8 quarters.
  • HMS Capital Management's Cantel Medical Corporation position peaked at $841K in Q3 2016.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on HMS Capital Management's 13F filing for Q3 2018, filed 2 Nov 2018.